← All trials
NCT00129337
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2005
- Primary completion
- Aug 1, 2009
- Completion date
- Aug 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 28
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Avid BioservicesLead sponsor
- University of ArizonaOverall official - principal investigator
- University of Texas at HoustonOverall official - principal investigator
- University of TennesseeOverall official - principal investigator
- Premiere OncologyOverall official - principal investigator
- Texas A&M UniversityOverall official - principal investigator
- The University of Texas, DallasOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.